Article
Interleukin 28 Polymorphisms and Hepatocellular Carcinoma Development after Direct Acting Antiviral Therapy for Chronic Hepatitis C.
Journal of gastrointestinal and liver diseases : JGLD - 9 Dec 2019
Simili Angelo, Mazzella Giuseppe, Ravaioli Federico, Festi Davide, Bacchi-Reggiani Maria Letizia, Porro Alberto, Bazzoli Franco, Azzaroli Francesco
Abstract excerpt
BACKGROUND AND AIMS: Cirrhotic patients with hepatitis C virus (HCV) infection remain at risk of developing hepatocellular carcinoma (HCC) even after the sustained virologic response (SVR). We aimed to evaluate whether the IL28 (rs12979860) single nucleotide polymorphism (SNP) may constitute a predisposing genetic factor and to identify the SVR patients at risk of HCC. METHODS: Two hundred patients undergoing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
